Surprising Fact The weight loss drug Wegovy could lower the risk of adverse cardiovascular events by 20%, according to data from a trial shared by Novo Nordisk in August
Individualising Care: Choosing the Right GLP-1RA for the Right Patient Not All GLP-1RAs are Made Equal GLP-1RAs are often differentiated according to structure and duration of action (Table 2) [9, 24, 45,46,47,48]
This pricing structure reflects the reality that the half-life benefit (weekly convenience and steady medication levels) applies equally whether you're at a lower starting dose or a higher therapeutic dose
Only a small number of patients discontinued treatment due to adverse effects: one experienced severe constipation, another was concerned about media-reported risks of pancreatitis and thyroid cancer, and a third reported dizziness and bloating
Stocked up again Second time ordering and the price is unbeatable for how well it works for me
Wash off the tissue retained by the mesh in isolation buffer
